Alzheimer's May Not Always Progress — What Neurologist Gayatri Devi Wants You to Know

Alzheimer's disease has long been framed as an irreversible, progressive deterioration with no meaningful room for reversal. This clip from The Drive podcast challenges that narrative directly, featuring neurologist Gayatri Devi who argues that the clinical picture is far more nuanced — and potentially more hopeful — than the field has traditionally acknowledged.

One of the most striking points raised is the prevalence of asymptomatic amyloid in the aging brain. A substantial proportion of cognitively healthy older adults harbor amyloid plaques at autopsy or on imaging, yet never develop clinical Alzheimer's. This observation raises fundamental questions about whether amyloid alone is sufficient to cause the disease or whether it requires co-factors such as neuroinflammation, vascular damage, or other triggers.

Devi describes cases that caused her to reconsider decades of conventional thinking: patients who, under the right circumstances, actually improved. While this remains controversial, she points to neuroinflammation as a potentially modifiable driver — one that connects Alzheimer's risk to systemic factors including viral infections (notably herpes viruses) and oral microbiome health, areas with a growing evidence base.

The conversation gives particular attention to women's elevated Alzheimer's risk. Women are not simply living longer into risk years — estrogen loss at menopause appears to directly affect brain metabolism, synaptic plasticity, and vulnerability to amyloid accumulation. Critically, low estrogen can produce cognitive symptoms such as brain fog and memory lapses that closely resemble early Alzheimer's, potentially leading to misdiagnosis.

For clinicians and health-conscious individuals alike, the implications are significant. Treating neuroinflammation, optimizing hormonal health in women, maintaining oral hygiene, and controlling viral reactivation may all represent actionable levers for dementia prevention and possibly even mitigation. This framing shifts Alzheimer's from a passive sentence to a condition with meaningful intervention points.